Vilanterol Trifenatate

Hovione has a proven track record in developing and manufacturing high performance APIs for the most demanding applications such as inhalation. With an unrivalled range of particle size reduction technologies for the production of tailor made API, featuring a near-perfect particle size distribution re...

ROUTE OF ADMINISTRATION: Oral, Topical  

REGULATORY STATUS: DEV

ROUTE OF ADMINISTRATION: Oral

REGULATORY STATUS: DEV

ROUTE OF ADMINISTRATION: Injectable

REGULATORY STATUS: DEV, TECH PACK

 Tiotropium Bromide for development trials with customized Particle Design, manufactured by wet polishing, resulting in Inhalation grade material with highly customizable PSD to befit your application.
Our technology and expertise range yields unmatched impurity profiles with highly reproducib...

Umeclidinium Bromide for formulation development trials with customized Particle Engineering, resulting in Inhalation grade material with highly customizable PSD to enhance your formulation’s performance. Our technology and expertise yields unmatched impurity profiles with highly reproducibility betwe...

Hovione helps you bring new medicines to patients in an unprecedented speed.

As a fully integrated CDMO, we offer over 60 years’ experience in chemical process development and manufacture of APIs. Our more recent capabilities in Drug Product together with our innovative science, the most up-to-...

Hovione is the leader in Spray Drying, thanks to the largest capacity, the best scale-up science and the most experienced team.

Spray drying is a continuous process that can be used for multiple applications. Over the last 15 years, the technology has been used for the production of solid ...

At Hovione we can tailor-make particle size distributions through complex particle engineering technologies, like wet-polishing and monosep, in ranges suitable for inhalation and incorporate desired morphology characteristics into your API. We are also able to start with a Hovione-produced API and develop ...

Hovione's APIs offer impeccable chemical purity and unique product performance.

High value applications Hovione provides off-patent APIs that can be used with confidence where the choice of active ingredient is critical.
• Branded generics where quality and security of supply is paramount • Difficult to make AB rated generics such as nasal and inhalation products where devel...

Hot melt extrusion is a fast growing technology platform that is utilized to solve difficult formulation challenges, primarily in the area of solubilization.
n recent years Hot Melt Extrusion (HME) has been used extensively in solubility enhancement applications for polymer-based amorphous solid dispe...

The new 31,000-sq. ft building will bring additional commercial spray drying capacity for customers who favour US-based manufacturing

Hovione announced today the appointment of Dr. Jean-Luc Herbeaux as Chief Operating Officer (COO), effective May 1st, 2020.

Hovione announced the signing of a partnership agreement with Ligand to significantly ramp up the production output of Captisol®

Ventofor Combi Fix delivered by the PowdAir Plus dry powder inhaler.

The 8Shot DPI is capable of delivering high doses of drug to the lungs.

TwinMax enabes delivery of doses up to 100 mg formulated as drug alone or engineered particles.

One-Site-Stop

This sun, this sea is what inspired the Portuguese to be the first to sail around the world five centuries ago. Today, discovery still requires courage, a willingness to take risk, and the best technologies. At Hovione this is what we do. We give clients what they cannot find elsewhere, we do well what is difficult. 
We work to help develop new and better medicines. Chemistry, processing and mathematical models are subjects we master, but it all begins and ends with the people. The almost 2000 committed, creative, rigorous, highly qualified team members coming from all parts of the world in which we operate. To contribute to their talent development is one of our major challenges and achievements.

Hovione #WeFightBack

Introduction to Hovione’s new formulation screening platform by Spray Drying Learn about the advantages of a platform that integrates in silico computational models, formulation, analytical development Get to know more about Hovione’s extensive expertise in Spray Drying This session was originally broadcast live as part of CPHI North America 2021

WATCH WEBINAR

The Coming of Age of Amorphous Solid Dispersions

In recent years, numerous drugs formulated as amorphous solid dispersions (ASDs) have been successfully commercialized, confirming the effectiveness of these technologies. Get to learn more with this scientific article. During the 10 days’ event meet with Hovione’s experts safely online and find how our experienced multi-disciplinary teams and their innovative work can help your project succeed.

READ ARTICLE The Coming of Age of Amorphous Solid Dispersions In recent years, numerous drugs formulated as amorphous solid dispersions (ASDs) have been successfully commercialized, confirming the effectiveness of these technologies. Get to learn more with this scientific article. During the 10 days’ event meet with Hovione’s experts safely online and find how our experienced multi-disciplinary teams and their innovative work can help your project succeed.

WATCH VIDEO For more than 60 years, Hovione has been dedicated to improving the lives of millions of patients, collaborating with our clients to create great medicines. In a time we need to adapt to new – and unprecedented – challenging circumstances, all our doors are open with virtual tours and Hovione team members are working enthusiastically with our partners, to solve complex problems and deliver solutions. Get to know more about us: During the 10 days’ event meet with Hovione’s experts safely online.